CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone

被引：1
|
作者：
Bose, Sminu [1 ]
Lee, Tristan [2 ]
Choi, Shaelyn [1 ]
Fazlollahi, Ladan [3 ]
Rasiej, Michael J. [4 ]
Schwartz, Gary K. [1 ]
Ingham, Matthew [1 ]
机构：
[1] Columbia Univ, Irving Med Ctr, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
[3] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA
[4] Columbia Univ, Irving Med Ctr, Dept Radiol, New York, NY USA
来源：
JCO PRECISION ONCOLOGY | 2022年 / 6卷
关键词：
PEGYLATED-LIPOSOMAL DOXORUBICIN; PHASE-II; KINASE; VINCRISTINE; BLEOMYCIN; TRIAL; PD-L1; CDK6;
D O I：
10.1200/PO.21.00550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
    Afzal, Muhammad Zubair
    Mabaera, Rodwell
    Shirai, Keisuke
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [2] Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma
    Lim, Mir
    Muquith, Maishara
    Miramontes, Bernadette
    Espinoza, Magdalena
    Hsiehchen, David
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (09): : 1912 - 1916
  • [3] Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
    Wei, Spencer
    Levine, Jacob
    Cogdill, Alexandria
    Zhao, Yang
    Anang, Nana-Ama
    Andrews, Miles
    Sharma, Padmanee
    Wang, Jing
    Wargo, Jennifer
    Pe'er, Dana
    Allison, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Distinct cellular mechanisms mediate anti-CTLA-4 and anti-PD-1 checkpoint blockade
    Wei, Spencer C.
    Levine, Jacob H.
    Pe'er, Dana
    Allison, James P.
    CANCER RESEARCH, 2017, 77
  • [5] Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
    Wei, Spencer C.
    Levine, Jacob H.
    Cogdill, Alexandria P.
    Zhao, Yang
    Anang, Nana-Ama A. S.
    Andrews, Miles C.
    Sharma, Padmanee
    Wang, Jing
    Wargo, Jennifer A.
    Pe'er, Dana
    Allison, James P.
    CELL, 2017, 170 (06) : 1120 - 1133
  • [6] Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy
    Cesmeci, E.
    Guven, D. C.
    Aktas, B. Y.
    Aksoy, S.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1766 - 1769
  • [7] Combining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone
    Hsu, Emily
    Eton, Omar
    Patel, Akshay, V
    Cartun, Richard
    Earle, Jonathan S.
    Mnayer, Laila O.
    Kotowitz, Jennifer
    Yu, Peter P.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (08) : 901 - 904
  • [8] Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer Biomarkers of Response and Resistance
    Maroun, Christopher A.
    Mandal, Rajarsi
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2021, 54 (04) : 751 - 759
  • [9] Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
    Gide, Tuba N.
    Quek, Camelia
    Menzies, Alexander M.
    Tasker, Annie T.
    Shang, Ping
    Holst, Jeff
    Madore, Jason
    Lim, Su Yin
    Velickovic, Rebecca
    Wongchenko, Matthew
    Yan, Yibing
    Lo, Serigne
    Carlino, Matteo S.
    Guminski, Alexander
    Saw, Robyn P. M.
    Pang, Angel
    McGuire, Helen M.
    Palendira, Umaimainthan
    Thompson, John F.
    Rizos, Helen
    da Silva, Ines Pires
    Batten, Marcel
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    CANCER CELL, 2019, 35 (02) : 238 - +
  • [10] CALORIC RESTRICTION SENSITIZES MELANOMA TO ANTI-PD-1 IMMUNE CHECKPOINT INHIBITION
    Melucci, Alexa
    Qin, Shuyang
    Chacon, Alexander
    Jewell, Rachel
    Prieto, Peter
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A618 - A618
12345